Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
about
Insomnia pharmacotherapyUpdate on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary carePsychiatric disorders and sleepHealthcare use in adults with insomnia: a longitudinal study.Ramelteon: a novel hypnotic indicated for the treatment of insomniaDiagnosis and treatment of chronic insomnia.Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.Clinical guideline for the evaluation and management of chronic insomnia in adults.Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.Prevalence and factors associated with off-label antidepressant prescriptions for insomniaEfficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomniaEffect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic ApproachesEffects of doxepin on brain-derived neurotrophic factor, tumor necrosis factor alpha, mitogen-activated protein kinase 14, and AKT1 genes expression in rat hippocampus.The effects of doxepin on stress-induced learning, memory impairments, and TNF-α level in the rat hippocampus.Management of insomnia: update and new approaches.Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future HorizonsWhich symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?Effects of different doses of doxepin on passive avoidance learning in rats.Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviors via the activation of GABAA-ergic systems in rodents.Sleep neurobiology from a clinical perspective.Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Efficacy and safety evaluation of citalopram and doxepin on sleep quality in comorbid insomnia and anxiety disorders.Antidepressant and Antipsychotic Drugs.Mechanism underlying the effects of doxepin on β-amyloid -induced memory impairment in rats.
P2860
Q24623757-78CC46B5-26D7-4B73-9D51-C82265EA1083Q24670611-CBC972F7-9F53-428E-953B-BE4ED1EEA4E3Q27007685-81BE04A5-57C9-4DC8-BB7B-496991A73E9AQ33806183-B11D0E8A-4E6B-43E6-95FE-DD4085F84EF6Q33894678-C8160859-6907-401A-B7EA-D062DEFA57FAQ34075878-6DBF855B-C085-45DB-AFB7-656E6CAA8861Q34197699-FB847A98-CBC1-4571-8C16-08475E1C8952Q34852294-08BE84EC-231A-49B3-A396-B8C4A31E6AF7Q35032530-5DC460AC-B644-4112-B9D1-F95B313959C1Q35187003-723F14DF-0840-4600-93D7-F2DEF88A7244Q35217790-A5F466EA-A6D5-4B93-B398-02C2D32AEE6FQ35615485-3539A1E1-C0F2-4381-A931-E4141180CB7DQ36151458-C6CC5AC1-96B4-467E-96A0-82287CB686AFQ36165434-E1296718-C979-40E0-A85A-E5AECB3EE9C7Q36206388-8FE52DAE-4737-4C59-8C8C-4A6288636692Q36406458-FB7FF95D-D1D3-4993-98FE-08E298CDFA1CQ36779811-1E9D14A7-5947-4F4C-AAC1-A8D7D9263CD3Q37149325-94399705-6B44-441E-9A7D-86FC783665FFQ37250950-5F2451C0-76A4-4D4D-82FA-631C1F3DA5DFQ37271655-FB778E1C-D2C5-44CD-A4D9-D8388005F709Q37559568-F5100EBF-F6E8-4CB9-8D34-0AE85771925DQ37897942-45D871E2-DED3-4E06-ADF8-C00C73071F97Q39044821-1925817B-B9AE-4113-8E23-688BAB64E5BAQ40257862-0CBA1948-390B-48F2-BEE7-52AC21093734Q42018725-53223561-B9F2-44D6-9E16-098A36DEF4F2Q44481331-A49BEB51-FAEE-444C-90BB-F585B3214A8D
P2860
Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@ast
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@en
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@nl
type
label
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@ast
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@en
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@nl
prefLabel
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@ast
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@en
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@nl
P2093
P1476
Doxepin in the treatment of pr ...... blind, polysomnographic study.
@en
P2093
Rodenbeck A
Voderholzer U
P304
P577
2001-06-01T00:00:00Z